Smallpox

Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS

A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.

MVA Post-Event: Administration Timing and Boost Study

A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age

High Dose IMVAMUNE® in Vaccinia-Naive Individuals

Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure

Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults

Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders

Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days

Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG

Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)

Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination

Post-licensure Department of Defense (DOD) Screening Accuracy Study in Military Personnel

Safety Surveillance Study of ACAM2000® Vaccinia Vaccine

Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults

Study of the Safety, Tolerability, Pharmacokinetics of NIOCH-14 in Volunteers Aged 18-50 Years

Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years

Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years

A Phase 4, Observational Field Study to Evaluate TPOXX in Patients With Smallpox